nach oben

International Journal of Behavioral Medicine

Erschienen in:

01.06.2013

The Distinction Between “Medically Unexplained” and “Medically Explained” in the Context of Somatoform Disorders

verfasst von: Kristina Klaus, Winfried Rief, Elmar Brähler, Alexandra Martin, Heide Glaesmer, Ricarda Mewes

Erschienen in: International Journal of Behavioral Medicine | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Medically unexplained symptoms (MUS) currently constitute the main diagnostic criterion of somatoform disorders. It has been proposed that the required dichotomization of somatic complaints into MUS and medically explained symptoms (MES) should be abandoned in DSM-V. The present study investigated complaints in the general population in order to evaluate the relevance of a distinction between MUS and MES.

Methods

Three hundred twenty-one participants from a population-based sample were interviewed by telephone to assess symptoms present during the previous 12 months. Complaints were examined in terms of health care use, diagnoses made by the physician and degree of impairment. At the 1-year follow-up, 244 subjects were re-interviewed in order to explore the stability of symptoms.

Results

The complaints frequently prompted participants to seek medical health care (several pain and pseudoneurological symptoms led to a doctors' visit in >80 % of cases), although etiological findings rarely suggested a medical pathology (occasionally <30 %). MUS and MES proved, to an equal degree, to impair individuals and prompt a change in lifestyle. Pain caused the worst impairment compared with other symptoms. The most prevalent MUS and MES were characterized by a transient course (approximately 60 % remitted, 55 % newly emerged to follow-up), although various unexplained pain complaints tended to be persistent (e.g., back pain 67 %). Remarkably, the appraised etiology as explained or unexplained changed from baseline to follow-up in many persisting symptoms (20 % MUS → MES, 50 % MES → MUS).

Conclusions

In principal, MUS and MES resulted in comparable impairment and stability. Due to conceptual and methodological difficulties, classification criteria for somatoform disorders should not be restricted to somatic aspects of the symptomatology.

Two persons with missing values in the PHQ-15 were not assigned to either of the two categories.

In order to facilitate statistical analyses due to the increased quantity of cases.

Complaints being most relevant in the population. Results of Fig. 2 could be confirmed taking all 49 symptoms into account.

Female-specific (n = 203).

Kroenke K, Price RK. Symptoms in the community: prevalence, classification, and psychiatric comorbidity. Arch Intern Med. 1993;153(21):2474–80.PubMedCrossRef

Khan AA, Khan A, Harezlak J, Tu W, Kroenke K. Somatic symptoms in primary care: etiology and outcome. Psychosomatics. 2003;44(6):471–8.PubMedCrossRef

Kroenke K, Mangelsdorff AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med. 1989;86(3):262–6.PubMedCrossRef

Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res. 2001;51(1):361–7.PubMedCrossRef

Hiller W, Rief W, Braehler E. Somatization in the population: from mild bodily misperceptions to disabling symptoms. Soc Psychiatry Psychiatr Epidemiol. 2006;41(9):704–12.PubMedCrossRef

Eriksen HR, Svendsrød R, Ursin G, Ursin H. Prevalence of subjective health complaints in the Nordic European countries in 1993. Eur J Public Health. 1998;8(4):294–8.CrossRef

Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol. 2005;15(4):357–76.PubMedCrossRef

Leiknes KA, Finset A, Moum T, Sandanger I. Methodological issues concerning lifetime medically unexplained and medically explained symptoms of the Composite International Diagnostic Interview: a prospective 11-year follow-up study. J Psychosom Res. 2006;61(2):169–79.PubMedCrossRef

McFarlane AC, Ellis N, Barton C, Browne D, van Hooff M. The conundrum of medically unexplained symptoms: questions to consider. Psychosomatics. 2008;49(5):369–77.PubMedCrossRef

10.

Sharpe M, Mayou R, Walker J. Bodily symptoms: new approaches to classification. J Psychosom Res. 2006;60(4):353–6.PubMedCrossRef

11.

Koch H, van Bokhoven MA, Bindels PJ, van der Weijden T, Dinant GJ, ter Riet G. The course of newly presented unexplained complaints in general practice patients: a prospective cohort study. Fam Pract. 2009;26(6):455–65.PubMedCrossRef

12.

Brown RJ. Introduction to the special issue on medically unexplained symptoms: background and future directions. Clin Psychol Rev. 2007;27(7):769–80.PubMedCrossRef

13.

Creed F. Medically unexplained symptoms—blurring the line between “mental” and “physical” in somatoform disorders. J Psychosom Res. 2009;67(3):185–7.PubMedCrossRef

14.

Dimsdale J, Creed F. The proposed diagnosis of somatic symptom disorders in DSM-V to replace somatoform disorders in DSM-IV—a preliminary report. J Psychosom Res. 2009;66(6):473–6.PubMedCrossRef

15.

Loewe B, Mundt C, Herzog W, Brunner R, Backenstrass M, Kronmueller K, et al. Validity of current somatoform disorder diagnoses: perspectives for classification in DSM-V and ICD-11. Psychopathology. 2008;41(1):4–9.CrossRef

16.

Hessel A, Geyer M, Hinz A, Braehler E. Utilization of the health care system due to somatoform complaints—results of a representative survey. Z Psychosom Med Psychother. 2005;51(1):38–56.PubMed

17.

Fink P, Sørensen L, Engberg M, Holm M, Munk-Jørgensen P. Somatization in primary care: prevalence, health care utilization, and general practitioner recognition. Psychosomatics. 1999;40(4):330–8.PubMedCrossRef

18.

Dirkzwager AJ, Verhaak PF. Patients with persistent medically unexplained symptoms in general practice: characteristics and quality of care. BMC Fam Pract 2007;8(33).

19.

Harris AM, Orav EJ, Bates DW, Barsky AJ. Somatization increases disability independent of comorbidity. J Gen Intern Med. 2009;24(2):155–61.PubMedCrossRef

20.

Kisely SR, Goldberg DP. The effect of physical ill health on the course of psychiatric disorder in general practice. BJP. 1997;170(6):536–40.CrossRef

21.

Kisely S, Goldberg D, Simon G. A comparison between somatic symptoms with and without clear organic cause: results of an international study. Psychol Med. 1997;27(5):1011–9.PubMedCrossRef

22.

Kisely S, Simon G. An international study comparing the effect of medically explained and unexplained somatic symptoms on psychosocial outcome. J Psychosom Res. 2006;60(2):125–30.PubMedCrossRef

23.

Kroenke K, Spitzer RL, Williams JB, Linzer M, Hahn SR, deGruy FV, et al. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med. 1994;3(9):774–9.PubMedCrossRef

24.

Robins LN. Using survey results to improve the validity of the standard psychiatric nomenclature. Arch Gen Psychiatry. 2004;61(12):1188–94.PubMedCrossRef

25.

Rief W, Rojas G. Stability of somatoform symptoms—implications for classification. Psychosom Med. 2007;69(9):864–9.PubMedCrossRef

26.

Kroenke K, Jackson JL. Outcome in general medical patients presenting with common symptoms: a prospective study with a 2-week and a 3-month follow-up. Fam Pract. 1998;15(5):398–403.PubMedCrossRef

27.

Leiknes KA, Finset A, Moum T, Sandanger I. Course and predictors of medically unexplained pain symptoms in the general population. J Psychosom Res. 2007;62(2):119–28.PubMedCrossRef

28.

Mewes R, Rief W, Braehler E, Martin A, Glaesmer H. Lower decision threshold for doctor visits as a predictor of health care use in somatoform disorders and in the general population. Gen Hosp Psychiatry. 2008;30(4):349–55.PubMedCrossRef

29.

Kingma EM, Tak LM, Huisman M, Rosmalen JG. Intelligence is negatively associated with the number of functional somatic symptoms. J Epidemiol Community Health. 2009;63(11):900–5.PubMedCrossRef

30.

Kroenke K, Spitzer RL, deGruy FV, Swindle R. A symptom checklist to screen for somatoform disorders in primary care. Psychosomatics. 1998;39(3):263–72.PubMedCrossRef

31.

Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64(2):258–66.PubMed

32.

Kroenke K, Spitzer RL, Williams JB, Loewe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345–59.PubMedCrossRef

33.

WHO. Schedules for clinical assessment in neuropsychiatry (SCAN). Geneva: World Health Organisation; 1995.

34.

Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37–46.CrossRef

35.

Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74.PubMedCrossRef

36.

Feinstein AR, Cicchetti DV. High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol. 1990;43(6):543–9.PubMedCrossRef

37.

Shankar V, Bangdiwala SI. Behavior of agreement measures in the presence of zero cells and biased marginal distributions. J Appl Stat. 2008;35(4):445–64.CrossRef

38.

Rief W, Nanke A, Emmerich J, Bender A, Zech T. Causal illness attributions in somatoform disorders: associations with comorbidity and illness behavior. J Psychosom Res. 2004;57(4):367–71.PubMed

39.

Rief W, Mewes R, Martin A, Glaesmer H, Braehler E. Are psychological features useful in classifying patients with somatic symptoms? Psychosom Med. 2010;72(7):648–55.PubMedCrossRef

40.

Simon GE, Gureje O. Stability of somatization disorder and somatization symptoms among primary care patients. Arch Gen Psychiatry. 1999;56(1):90–5.PubMedCrossRef

41.

Sharpe M, Stone J, Hibberd C, Warlow C, Duncan R, Coleman R, et al. Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcome. Psychol Med. 2010;40(4):689–98.PubMedCrossRef

42.

Martin A, Buech A, Schwenk C, Rief W. Memory bias for health-related information in somatoform disorders. J Psychosom Res. 2007;63(6):663–71.PubMedCrossRef

43.

Pauli P, Alpers GW. Memory bias in patients with hypochondriasis and somatoform pain disorder. J Psychosom Res. 2002;52(1):45–53.PubMedCrossRef

44.

Grabe HJ, Meyer C, Hapke U, Rumpf HJ, Freyberger HJ, Dilling H, et al. Somatoform pain disorder in the general population. Psychother Psychosom. 2003;72(2):88–94.PubMedCrossRef

45.

Froehlich C, Jacobi F, Wittchen HU. DSM-IV pain disorder in the general population: an exploration of the structure and threshold of medically unexplained pain symptoms. Eur Arch Psychiatry Clin Neurosci. 2006;256(3):187–96.CrossRef

46.

Creed F, Guthrie E, Fink P, Henningsen P, Rief W, Sharpe M, et al. Is there a better term than “medically unexplained symptoms”? J Psychosom Res. 2010;68(1):5–8.PubMedCrossRef

47.

Deary V, Chalder T, Sharpe M. The cognitive behavioural model of medically unexplained symptoms: a theoretical and empirical review. Clin Psychol Rev. 2007;27(7):781–97.PubMedCrossRef

48.

Rief W, Broadbent E. Explaining medically unexplained symptoms—models and mechanisms. Clin Psychol Rev. 2007;27(7):821–41.PubMedCrossRef

49.

Sharpe M, Mayou R. Somatoform disorders: a help or hindrance to good patient care? Br J Psychiatry. 2004;184(6):465–7.PubMedCrossRef

50.

Henningsen P, Fink P, Hausteiner-Wiehle C, Rief W. Terminology, classification and concepts. In: Creed F, Henningsen P, Fink P, editors. Medically unexplained symptoms, somatisation and bodily distress. New York: Cambridge University Press; 2011.

51.

Rief W, Sharpe M. Somatoform disorders—new approaches to classification, conceptualization, and treatment. J Psychosom Res. 2004;56(4):387–90.PubMedCrossRef

52.

Martin A, Rief W. Relevance of cognitive and behavioral factors in medically unexplained syndromes and somatoform disorders. Psychiatr Clin North Am. 2011;34(3):565–78.PubMedCrossRef

53.

Hausteiner C, Bornschein S, Bubel E, Groben S, Lahmann C, Grosber M, et al. Psychobehavioral predictors of somatoform disorders in patients with suspected allergies. Psychosom Med. 2009;71(9):1004–11.PubMedCrossRef

54.

Voigt K, Nagel A, Meyer B, Langs G, Braukhaus C, Loewe B. Towards positive diagnostic criteria: a systematic review of somatoform disorder diagnoses and suggestions for future classification. J Psychosom Res. 2010;68(5):403–14.PubMedCrossRef

55.

Rief W, Mewes R, Martin A, Glaesmer H, Braehler E. Evaluating new proposals for the psychiatric classification of patients with multiple somatic symptoms. Psychosom Med. 2011;73(9):760–8.PubMedCrossRef

56.

Steinbrecher N, Koerber S, Frieser D, Hiller W. The prevalence of medically unexplained symptoms in primary care. Psychosomatics. 2011;52(3):263–71.PubMedCrossRef

Titel: The Distinction Between “Medically Unexplained” and “Medically Explained” in the Context of Somatoform Disorders
verfasst von: Kristina Klaus
Winfried Rief
Elmar Brähler
Alexandra Martin
Heide Glaesmer
Ricarda Mewes
Publikationsdatum: 01.06.2013
Verlag: Springer US
Erschienen in: International Journal of Behavioral Medicine / Ausgabe 2/2013
Print ISSN: 1070-5503
Elektronische ISSN: 1532-7558
DOI: https://doi.org/10.1007/s12529-012-9245-2

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

The Distinction Between “Medically Unexplained” and “Medically Explained” in the Context of Somatoform Disorders

Abstract

Purpose

Methods

Results

Conclusions

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2013

Intervention Format and Delivery Preferences Among Young Adult Cancer Survivors

Guest Editorial: Functional Somatic Syndromes

How Should Functional Somatic Syndromes Be Diagnosed?

Prevalence, Overlap, and Predictors of Functional Somatic Syndromes in a Student Sample

Influence of Symptom Expectancies on Stair-Climbing Performance in Chronic Fatigue Syndrome: Effect of Study Context

Relationships of Personality Factors to Perceived Stress, Depression, and Oral Lichen Planus Severity